Aardvark Therapeutics is a San Diego biopharmaceutical company developing oral medicines that aim to reduce hunger in metabolic conditions. It last closed at $1.18 on Nov 17, down 6.35% on the day. The average 12-month price target from 2 analysts is $6.00 (+408.5% from the last close), with a high of $10.00 and a low of $2.00.
Only 2 firms rated AARD in the past 90 days, not enough for a consensus
Average 12-month target
$6.00
▲ 408.5% upside
Based on 2 analysts who set a price target on AARD in the past 90 days. The average target is $6.00, with a high of $10.00 and a low of $2.00, compared with the last close of $1.18.
Low $2.00Avg $6.00High $10.00
Blue marker: last close $1.18
Highest target$10.00
Average target$6.00
Lowest target$2.00
Latest rating changes
Jones TradingMaintained
Oct 27Buy$10
HC Wainwright & Co.Target lowered
Oct 26Hold$4 → $2
HC Wainwright & Co.Target lowered
Oct 19Hold$6 → $4
HC Wainwright & Co.Reiterated
Jul 20Hold$6
Morgan StanleyDowngrade
May 15Sell$7 → $3
Date
Firm
Action
Rating
Price target
Oct 27
Jones Trading
Maintained
Buy
$10
Oct 26
HC Wainwright & Co.
Target lowered
Hold
$4 → $2
Oct 19
HC Wainwright & Co.
Target lowered
Hold
$6 → $4
Jul 20
HC Wainwright & Co.
Reiterated
Hold
$6
May 15
Morgan Stanley
Downgrade
Sell
$7 → $3
Loading…
Technical Analysis
AARD · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 36% below its 20 day and 205% below its 50 day average. It is 368% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 30), oversold. The nearest support is the swing low (Nov 6) at $1.09, and the nearest resistance the Pivot at $1.22.
Short trendBearish
Long trendBearish
MomentumFading
StretchOversold
VolatilityHigh, 28.8%/day
Key levels
$16.6052 week high+1306.8%
$5.53200 day average+368.6%
$4.96100 day average+320.3%
$3.5950 day average+204.2%
$1.68Swing high (Nov 11)+42.4%
$1.6020 day average+35.6%
$1.34Pivot R1+13.6%
$1.22Pivot+3.4%
$1.18Last close
$1.09Swing low (Nov 6)−7.6%
$1.06Pivot S1−10.2%
$0.9352 week low−21.2%
Indicators
RSI (14)
29.80
Oversold below 30
Oversold
MACD
-0.69
Above its signal line
Bullish
Stochastic
28.3
Middle of its range
Neutral
ADX (14)
42.5
Strong downtrend
Williams %R
-84.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-51.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.1%
Change over 10 sessions
Bearish
ATR (14)
$0.34
Typical daily range, 28.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityHigh, 104.6%/day
Key levels
$16.6052 week high+1306.8%
$5.53200 day average+368.6%
$4.96100 day average+320.3%
$3.5950 day average+204.2%
$1.68Swing high (Nov 11)+42.4%
$1.6020 day average+35.6%
$1.34Pivot R1+13.6%
$1.22Pivot+3.4%
$1.18Last close
$1.09Swing low (Nov 6)−7.6%
$1.06Pivot S1−10.2%
$0.9352 week low−21.2%
Indicators
RSI (14)
29.27
Oversold below 30
Oversold
MACD
-1.43
Below its signal line
Bearish
Stochastic
4.3
Near the bottom of its range
Oversold
ADX (14)
21.8
Weak trend
Williams %R
-96.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-138.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−77.0%
Change over 10 sessions
Bearish
ATR (14)
$1.23
Typical daily range, 104.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for AARD
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AARD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in AARD in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AARD is in one of them and how their past AARD trades turned out.
Aardvark Therapeutics is a biopharmaceutical company based in San Diego, California, that develops small molecule medicines aimed at reducing hunger. Its work centers on compounds that act on bitter taste receptors in the gut, which are designed to prompt the body to release its own appetite-related hormones. Its lead candidate, ARD-101, is an oral drug being studied for hyperphagia, an extreme hunger condition associated with Prader-Willi syndrome. The company has no approved products yet and aims to serve patients with metabolic conditions and the clinicians who treat them.